Phase III study of gemcitabine compared with UFT [tegafur/uracil] in patients with completely resected pathological stage IB-IIIa non small cell lung cancer.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Gemcitabine (Primary) ; Tegafur/uracil
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 27 Sep 2011 Results presented at the 2011 European Multidisciplinary Cancer Congress.
- 29 May 2009 New source identified and integrated (UMIN record C000000116).
- 01 Nov 2005 New trial record.